Antidepressant potential of agmatine: Effects on hypothalamic neurogenesis in rats with depressive behavior
- 29 September 2026
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 269
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- ‘The effect of neuropeptide Y1 receptor agonist on hypothalamic neurogenesis in rat experimental depression model’Metabolic Brain Disease, 2024
- Does Sertraline Affect Hypothalamic Food Intake Peptides in the Rat Experimental Model of Chronic Mild Stress-Induced Depression?Neurochemical Research, 2022
- Do corticosterone levels predict female depressive‐like behavior in rodents?Journal of Neuroscience Research, 2020
- Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta‐analysisJournal of Neuroscience Research, 2020
- Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brainBrain Research Bulletin, 2018
- Tanycytes and hypothalamic control of energy metabolismGlia, 2018
- Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathwayBrain Research, 2017
- The Beneficial Impact of Antidepressant Drugs on Prenatal Stress-Evoked Malfunction of the Insulin-Like Growth Factor-1 (IGF-1) Protein Family in the Olfactory Bulbs of Adult RatsNeurotoxicity Research, 2015
- Cellular changes in the postmortem hippocampus in major depressionBiological Psychiatry, 2004
- Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluationPsychopharmacology, 1997